USD 24.5
(-6.45%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 233.9 Million | 300.07 Million | 185.17 Million | 97.23 Million | 171.3 Million |
Cost of Revenue | 142.88 Million | 137.13 Million | 58.44 Million | 50.9 Million | 58.44 Million |
Gross Profit | 91.02 Million | 162.93 Million | 126.73 Million | 46.32 Million | 112.85 Million |
Operating Expenses | 56.16 Million | 9.06 Million | 72.83 Million | 66.95 Million | 75.97 Million |
Selling, General and Administrative Expenses | 56.16 Million | 9.06 Million | 11.99 Million | 8.65 Million | 11.25 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | 20 Thousand | 60.84 Million | 58.3 Million | 64.72 Million |
Cost and Expenses | 199.05 Million | 146.2 Million | 131.28 Million | 117.86 Million | 134.42 Million |
Operating Income | 34.85 Million | 153.86 Million | 53.89 Million | -20.61 Million | 36.88 Million |
Interest Expense | 5.27 Million | 4.15 Million | 3.2 Million | 4.67 Million | 4.82 Million |
Income Tax Expense | 61.94 Million | 3.2 Million | 3.22 Million | 4.7 Million | 4.87 Million |
Earnings before Tax | 42.2 Million | 118.9 Million | 18.11 Million | -8.85 Million | 35.88 Million |
Net Income | -21.57 Million | 118.9 Million | 18.11 Million | -13.55 Million | 35.88 Million |
Earnings Per Share Basic | -0.73 | 0.26 | 0.62 | -0.48 | 1.23 |
Earnings Per Share Diluted | -0.73 | 0.26 | 0.62 | -0.48 | 1.23 |
Weighted Average Shares Outstanding | 29.55 Million | 438.62 Million | 28.52 Million | 28.52 Million | 28.52 Million |
Weighted Average Shares Outstanding (Diluted) | 29.55 Million | 438.62 Million | 28.52 Million | 28.52 Million | 28.52 Million |
Gross Margin | 0.39 | 0.54 | 0.68 | 0.48 | 0.66 |
EBIT Margin | 0.55 | 0.73 | 0.62 | 0.39 | 0.59 |
Profit Margin | -0.09 | 0.40 | 0.10 | -0.14 | 0.21 |
EBITDA | 129.22 Million | 186.78 Million | 82.16 Million | 54.12 Million | 105.43 Million |
Earnings Before Tax Margin | 0.15 | 0.51 | 0.29 | -0.21 | 0.22 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 58.28 Million | 66.59 Million | 61.19 Million | 69.3 Million | 233.9 Million | 55.05 Million |
Cost of Revenue | 41.86 Million | 43.01 Million | 41.13 Million | 42.94 Million | 142.88 Million | 34.15 Million |
Gross Profit | 16.41 Million | 23.58 Million | 20.05 Million | 26.36 Million | 91.02 Million | 20.9 Million |
Operating Expenses | 11.62 Million | 6.77 Million | 6.97 Million | 6.47 Million | 56.16 Million | 4.96 Million |
Selling, General and Administrative Expenses | 5.23 Million | 6.77 Million | 6.97 Million | 6.47 Million | - | 4.96 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 6.39 Million | -2000.00 | 31 Thousand | 41 Thousand | 140 Thousand | 49 Thousand |
Cost and Expenses | 11.62 Million | 49.78 Million | 48.11 Million | 49.42 Million | 199.05 Million | 39.11 Million |
Operating Income | 8.98 Million | 16.81 Million | 13.07 Million | 19.88 Million | 34.85 Million | 15.93 Million |
Interest Expense | -2.72 Million | 2.58 Million | 2.2 Million | 1.81 Million | 5.27 Million | 1.16 Million |
Income Tax Expense | -6.22 Million | 3.67 Million | -731 Thousand | 15.56 Million | 61.94 Million | -796 Thousand |
Earnings before Tax | 23.66 Million | 14.6 Million | -2.91 Million | 35.47 Million | 42.2 Million | -2.26 Million |
Net Income | 17.44 Million | 10.92 Million | -2.18 Million | 19.91 Million | -19.74 Million | -1.46 Million |
Earnings Per Share Basic | 0.58 | 0.36 | -0.07 | 0.61 | - | -0.04 |
Earnings Per Share Diluted | 0.53 | 0.33 | -0.07 | 0.61 | - | -0.04 |
Weighted Average Shares Outstanding | 30.07 Million | 30.04 Million | 29.93 Million | 32.81 Million | 29.55 Million | 32.81 Million |
Weighted Average Shares Outstanding (Diluted) | 32.98 Million | 33.02 Million | 29.93 Million | 32.81 Million | 29.55 Million | 32.81 Million |
Gross Margin | 0.28 | 0.35 | 0.33 | 0.38 | 0.39 | 0.38 |
EBIT Margin | 0.57 | 0.63 | 0.60 | 0.66 | - | 0.64 |
Profit Margin | 0.30 | 0.16 | -0.04 | 0.29 | -0.08 | -0.03 |
EBITDA | 33.41 Million | 42.12 Million | 36.62 Million | 45.43 Million | - | 35 Million |
Earnings Before Tax Margin | 0.15 | 0.25 | 0.21 | 0.29 | 0.15 | 0.29 |
1082
STARHEALTH
VRNS
AMAG
CSED3
BIOSK